LEO Pharma Announces Positive 16-Week Interim Results for ADHAND Trial for Tralokinumab in Patients with Moderate-to-Severe Atopic Dermatitis on the Hands who are Candidates for Systemic Therapy
ADHAND is a phase 3b placebo-controlled clinical trial evaluating the efficacy and safety of tralokinumab in adult patients living with moderate-to-severe atopic... Read more.
TELUS Digital advances special committee process in connection with TELUS Corporation’s non-binding proposal
VANCOUVER, British Columbia–(BUSINESS WIRE)–TELUS Digital Experience (TELUS Digital or the Company) (NYSE and TSX: TIXT), a leading global technology... Read more.
Merck to Acquire Verona Pharma, Expanding its Portfolio to Include Ohtuvayre® (ensifentrine), a First-In-Class COPD Maintenance Treatment for Adults and Expected to Drive Growth into the Next Decade
Acquisition aligns with Merck’s science-led business development strategy and expands pipeline and portfolio of treatments for cardio-pulmonary diseases Merck... Read more.
Lydian Energy Secures $233M in Project Financing to Advance Battery Storage Projects Across Texas
ING and KeyBank provide Lydian’s first institutional financing for Pintail, Crane, and Headcamp BESS projects under Excelsior Energy Capital’s Fund II WASHINGTON... Read more.
Trane Technologies Schedules Second Quarter 2025 Earnings Conference Call
SWORDS, Ireland–(BUSINESS WIRE)–Trane Technologies plc (NYSE:TT), a global climate innovator, will host a conference call to discuss its second quarter... Read more.
Venture Global and SEFE Announce Expansion of LNG Partnership
ARLINGTON, Va.–(BUSINESS WIRE)–Today, Venture Global, Inc. (NYSE: VG) and Securing Energy for Europe GmbH (SEFE) announced the finalization of an agreement... Read more.
Third Partners Releases Streamlined SB-261 Compliance Strategy for Companies Ahead of California Climate Risk Reporting Deadline
MORRISTOWN, N.J. & MINNEAPOLIS–(BUSINESS WIRE)–Third Partners, a full-service sustainability management consulting firm, is using AI-powered tools... Read more.
Franklin BSP Realty Trust, Inc. Schedules Second Quarter 2025 Earnings Release and Conference Call
NEW YORK–(BUSINESS WIRE)–Franklin BSP Realty Trust, Inc. (NYSE: FBRT) (“FBRT” or the “Company”) today announced that it will release its second... Read more.
Exact Sciences Announces Medicare Coverage for Oncodetect™ Molecular Residual Disease Test in Colorectal Cancer
MADISON, Wis.–(BUSINESS WIRE)–Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that... Read more.
AirMDR Raises $15.5M to Bring AI Analyst-Driven MDR to Every Enterprise
New Investment Aimed at Scaling Sales and Marketing Efforts to Meet Demand for AI SOC as a Service MENLO PARK, Calif.–(BUSINESS WIRE)–#AI—AirMDR,... Read more.